Oncolytics Biotech: A Promising Leader in the Next-Gen Immunotherapy Landscape
We see Oncolytics Biotech as a rising star in the immunotherapy field, pushing boundaries with its innovative drug, pelareorep. This company targets tough cancers like pancreatic ductal adenocarcinoma, offering hope where treatments are scarce. Its strong trial results and strategic planning make it a standout in the biotech sector. The immunotherapy landscape is evolving fast,…